GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocCheck AG (XTER:AJ91) » Definitions » 3-Year EBITDA Growth Rate

DocCheck AG (XTER:AJ91) 3-Year EBITDA Growth Rate : 26.60% (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is DocCheck AG 3-Year EBITDA Growth Rate?

DocCheck AG's EBITDA per Share for the six months ended in Jun. 2023 was €0.81.

During the past 12 months, DocCheck AG's average EBITDA Per Share Growth Rate was -18.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 26.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 35.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 21.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of DocCheck AG was 62.00% per year. The lowest was -5.50% per year. And the median was 12.00% per year.


Competitive Comparison of DocCheck AG's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, DocCheck AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocCheck AG's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where DocCheck AG's 3-Year EBITDA Growth Rate falls into.



DocCheck AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


DocCheck AG  (XTER:AJ91) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


DocCheck AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of DocCheck AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


DocCheck AG (XTER:AJ91) Business Description

Traded in Other Exchanges
Address
Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Executives
Dr. Frank Antwerpes Board of Directors

DocCheck AG (XTER:AJ91) Headlines

No Headlines